Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility (Q45704226)

15 December 2017

title

Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility (English)

1 reference

15 December 2017

8

1 reference

15 December 2017

Massimo Galli

7

0 references

author name string

Elisabetta Bulgheroni

1

1 reference

15 December 2017

Francesco Croce

2

1 reference

15 December 2017

Paola Citterio

3

1 reference

15 December 2017

Ottavia Viganò

4

1 reference

15 December 2017

Raffaella Visonà

5

1 reference

15 December 2017

Eugenio Sala

6

1 reference

15 December 2017

publication date

1 January 2004

1 reference

Journal of Clinical Virology

15 December 2017

published in

1 reference

15 December 2017

volume

29

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

27-32

1 reference

Resistance to human immunodeficiency virus type 1 protease inhibitors.

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

The accuracy of reverse transcriptase from HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Multidrug Resistance Genotypes (Insertions in the β3–β4 Finger Subdomain and MDR Mutations) of HIV-1 Reverse Transcriptase from Extensively Treated Patients: Incidence and Association with Other Resistance Mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900082-9

7 January 2021

10.1016/S1386-6532(03)00082-9

Identifiers

DOI

1 reference

15 December 2017

1 reference